Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from ConvaTec ( (GB:CTEC) ) is now available.
Convatec Group Plc has scheduled its 2026 annual general meeting for 14:00 UK time on 21 May 2026 at its London headquarters on Eastbourne Terrace. The notice of meeting and proxy form have been dispatched to shareholders, filed with the UK National Storage Mechanism and made available on the company’s website, in line with Financial Conduct Authority disclosure requirements.
The announcement underscores Convatec’s adherence to UK listing and transparency rules, ensuring shareholders have timely access to AGM documentation and voting arrangements. This routine governance step supports investor engagement and regulatory compliance as the FTSE 100 medical technology group continues to operate at scale, following 2025 revenues of more than $2 billion.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on CTEC Stock
According to Spark, TipRanks’ AI Analyst, CTEC is a Neutral.
The score is driven primarily by solid underlying financial performance (growth, improving operating margins, positive free cash flow) and supportive guidance for continued growth and margin expansion. This is tempered by increased leverage and notable operational/regulatory risks flagged on the call, while valuation looks expensive and technicals appear near overbought despite an uptrend.
To see Spark’s full report on CTEC stock, click here.
More about ConvaTec
Convatec Group Plc is a global medical products and technologies company focused on solutions for managing chronic conditions. It holds leading positions in advanced wound care, ostomy care, continence care and infusion care, serving around 90 countries with products aimed at infection prevention, hard-to-heal wounds and at-risk skin, while helping improve patient outcomes and reduce care costs.
Average Trading Volume: 8,286,107
Technical Sentiment Signal: Strong Buy
Current Market Cap: £4.56B
For an in-depth examination of CTEC stock, go to TipRanks’ Overview page.